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OBJECTIVES: Generation of population cost estimates
for event-time data requires a sophisticated approach 
to account for the probability of incurring the event over
time. This research investigated the relationship of donor
and recipient factors with all-cause renal graft failure and
estimates of the cost of failure from a Medicare perspec-
tive. METHODS: A two-part econometric approach 
was used to determine Medicare claims attributable to all-
cause graft failure (including deaths). First, type-speciﬁc
hazard functions were estimated with Cox proportional
hazards models. Using data from USRDS for primary
renal transplants in adults between 1993-1998, we devel-
oped separate predictive models for transplants from
living and cadaveric donors after identifying covariates
associated with graft loss. Models were stratiﬁed by trans-
plant year and included donor and recipient characteris-
tics plus clinical variables including immunosuppression
therapies. Next, the log-transformed costs for patients
who experienced the event were modeled against the
covariates to estimate costs speciﬁcally associated with
failure at a given time point. For patients who did not
experience the event, predicted costs were generated
based on the model coefﬁcients and individual covariates.
Retransformation of the log costs included an adjustment
using residual smearing. The expected Medicare claims
associated with graft failure were calculated by combin-
ing the estimated cumulative hazards of graft failure with
the smeared estimate of the claims associated with the
event. RESULTS: For living donor transplants (N =
5831), expected Medicare claims attributed to renal
transplant graft failure were approximately $13,073 ±
$14,318 (median = $8,933; range = $560–$191,169) at
3 years post-transplant. For cadaveric donor transplants
(N = 22,941), the expected Medicare claims were 
approximately $15,075 ± $13,149 (median = $11,540;
range = $699–$214,184). CONCLUSIONS: These esti-
mates provide groundwork for population-based studies
to address the cost-effectiveness of various treatments to
delay or prevent graft loss. The method allows policy-
makers to assess population costs after taking into
account the probability of event occurrence.
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Healthcare resource utilization (HCRU) may be evaluated
through patient interviews in multicenter clinical trials
but the accuracy of self-reported data should be assessed.
OBJECTIVE: This study evaluated the consistency
between electronic record data and patient self-reported
HCRU for herpes zoster (HZ) through telephone inter-
views. METHODS: HZ patients (N = 116) were recruited
from a managed care organization in Boston. HZ-related
hospitalizations, Emergency Department (ED) visits, 
outpatient visits and telephone calls were compared 
separately, with further differentiation among outpatient
contacts with primary care providers and specialists.
Medication use comparisons were made for analgesics,
antivirals and other prescription medications. Judgments
of consistency were based on intraclass correlation 
coefﬁcients (ICC) unless data were sparse. RESULTS:
Two patients with HZ hospitalizations were found in the
electronic records versus three in the questionnaire. Four
patients with ED visits were found in the electronic
records versus 34 in the questionnaire. The ICC for 
outpatient visits was 0.46 (CI 0.06-0.85; nelectronic records =
268, nZHEQ = 265). The ICC for telephone calls was 0.51
(CI 0.06–0.96; nelectronic records = 87, nZHEQ = 110). By out-
patient provider type, the ICC ranged from 0.27 for
primary care visits to 0.84 for specialist visits. ICCs of
0.55, 0.64 and 0.56 were found for pain medications,
antiviral medications, and other medications, respec-
tively. CONCLUSION: Patient self-reported HCRU 
reasonably (ICC ≥ 0.4), but imperfectly matched the elec-
tronic records across most categories, with no systematic
bias observed. Patient misclassiﬁcation of urgent care
visits as ED visits may account for some of the observed
discrepancies between ED and primary care visits. This
study, which represents one of the ﬁrst efforts to evaluate
the design of a patient self-report HCRU questionnaire
for use in clinical trials, identiﬁed limitations to compar-
isons between the two types of data sources and offers
insight into potential improvements for the design and
validation of such questionnaires.
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OBJECTIVES: In economic and epidemiologic studies
utilizing longitudinal data, researchers often require a
ﬁxed follow-up period. By allowing differential follow-
up, researchers can eliminate one source of selection bias.
Our objective was to compare analyses of two study 
populations from the General Practice Research Database
(GPRD) differing only in length of follow-up time.
METHODS: Study population 1 (SP1; n = 28,643)
included patients with a given condition ﬁrst diagnosed
between June 1988 and February 1999. Study population
2 (SP2; n = 21,289) included only those patients in SP1
with at least a year of follow-up. Comorbid conditions,
resource use, and reasons for loss to follow-up were
